Cancer Research UK logo.
SearchDonate
  • Search

A trial of olaparib with radiotherapy and chemotherapy for glioblastoma (PARADIGM-2)

Overview

Cancer types:

Brain (and spinal cord) tumours

Status:

Closed

Phase:

Phase 1

Details

This trial is looking at whether a drug called olaparib improves the way radiotherapy and chemotherapy work. It is for people with a type of brain tumour called glioblastoma who:

  • are newly diagnosed

  • have recently had surgery

Cancer Research UK supports this trial.

Recruitment start: 15 November 2016

Recruitment end: 31 December 2024

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Anthony Chalmers

Supported by

Cancer Research UK

AstraZeneca

NHS Greater Glasgow and Clyde

The Brain Tumour Charity

University of Glasgow

Other information

This is Cancer Research UK trial number CRUKD/16/010.

Last reviewed: 02 Jan 2025

CRUK internal database number: 14194

Help and support